Page last updated: 2024-08-22

fluorescein and Neoplasms

fluorescein has been researched along with Neoplasms in 67 studies

Research

Studies (67)

Timeframe	Studies, this research(%)	All Research%
pre-1990	32 (47.76)	18.7374
1990's	2 (2.99)	18.2507
2000's	10 (14.93)	29.6817
2010's	20 (29.85)	24.3611
2020's	3 (4.48)	2.80

Authors

Authors	Studies
Low, PS; Luo, Q; Napoleon, JV; Srinivasarao, M; Zhang, B	1
Kim, J; Kim, KG; Lee, S; Yoon, K	1
Brady, DC; Chang, CJ; Chung, CY; Davis, JM; Lee, S; Posimo, JM; Tsang, T	1
Bratlie, KM; Rehman, TU	1
Dai, C; Deng, G; Kang, Y; Liu, X; Wang, Q; Wang, Y; Wu, Z; Zhao, J; Zhou, F	1
Gurzadyan, G; Liang, R; Liu, Z; Peng, X; Shi, W; Song, B; Song, F; Yin, H	1
Chu, H; Leamon, CP; Lee, YG; Low, PS; Lu, Y; Putt, KS; Srinivasarao, M	1
Lippard, SJ; Royzen, M; Song, Y; Suntharalingam, K; Yeung, JS	1
Kelderhouse, LE; Low, PS; Sturgis, JE; Vlashi, E	1
He, Z; Hong, T; Huang, J; Ma, J; Mao, W; Wang, T; Xiao, H; Zhou, X	1
Chen, YL; Cheng, JC; Chiu, YC; Shen, LJ; Wei, MF; Wu, FL; Yeh, TH	1
Cotton, J; Davies, B; Dzobo, K; Hunter, R; Kaschula, CH; Katz, AA; Kusza, DA; Lang, D; Ngarande, E; Parker, MI; Schäfer, G; Siyo, V; Tuveri, R	1
Huang, HL; Lee, GD; Li, HR; Liao, KC; Lu, PH; Yang, HC	1
Bonakdar, S; Keshvari, H; Khosroshahi, ME; Rezvani, HA; Tajabadi, M	1
Chen, XZ; Hoop, M; Hurter, C; Mushtaq, F; Nelson, BJ; Pané, S	1
MOORE, GE; PEYTON, WT	1
Drese, KS; Hahn, T; O'Sullivan, CK	1
Li, T; Li, X; Luo, J; Ng, MT; Quek, NM; Tan, CH; Wang, Y; Yuan, W; Zeng, H; Zhou, T	1
Hori, K; Nishihara, M; Shiraishi, K; Yokoyama, M	1
Carlson, AN; Exner, AA; Patel, RB; Solorio, L	1
Forbes, NS; Han, G; Kim, B; Kim, CK; Rotello, VM; Toley, BJ	1
Malta, JB; Mian, SI; Musch, DC; Rhoades, W; Shtein, RM; Soong, HK; Sugar, A	1
Kang, H; Kim, Y; Liu, H; Peng, L; Tan, W; Yan, J; Yang, H; Zhang, X; Zhu, Z	1
Insall, RH; Kalna, G; Muinonen-Martin, AJ; Veltman, DM	1
Brevet, D; Charasson, V; Durand, JO; Garcia, M; Gary-Bobo, M; Hocine, O; Loock, B; Maillard, P; Maynadier, M; Morère, A; Raehm, L; Richeter, S	1
Chen, H; Li, Z; Luo, Q; Luo, Y; Wang, Q; Yan, X; Yang, L; Zhang, B; Zhang, Z	1
Ali, SM; Olivo, M	1
CRAMER, H	1
HILL, JH	1
UMEDA, M	2
DE VINCENTIIS, M	1
GOLDSTEIN, MN; HIRAMOTO, R; PRESSMAN, D	1
LOUIS, CJ; VARASDI, G	1
BAUMLER, A; CARRUTHERS, C	1
HUGHES, PE; LOUIS, CJ	1
FINK, MA; MALMGREN, RA; MILLS, W	1
LOUIS, CJ	1
CAUDILL, CM; KOHL, DA; MARVIN, JF; MOORE, GE; WANG, JC	1
ASHKENAZY, M; DAVIS, L; MARTIN, J	1
ASHKENAZY, M; DAVIS, L; FIELDS, T; LeROY, GV; MARTIN, J	1
THOMA, GE; WOOLSEY, RD	2
JOHNSON, AB; SVIEN, HJ	1
BELCHER, EH; EVANS, HD	1
AUST, JB; CAUDILL, CM; CHOU, SN; MARVIN, JF; MOORE, GE; SMITH, GA	1
BIERMAN, HR; BYRON, RL; DOD, KS; KELLY, KH	1
BRILMAYER, C; CRAMER, H	3
PICCOLI, B	1
Frischer, JS; Holash, J; Huang, J; Kadenhe-Chiwishe, A; Kandel, JJ; Kim, ES; Lee, A; New, T; Pollyea, DA; Serur, A; Yamashiro, DJ; Yancopoulos, GD; Yokoi, A	1
Berg, T; Schust, J	1
HUBBARD, TB; MOORE, GE	1
Delehanty, JB; Lin, B; Shaffer, KM	1
Sampathkumar, SG; Yarema, KJ	1
Bai, Y; Liu, YJ; Stamenkovic, I; Wang, H; Xu, Y; Yu, Q	1
Tsien, RY	1
Landing, BH; Shapiro, DM	1
Nairn, RC; Nind, AP; Pihl, E; Rolland, JM	1
Hocking, GR; Nairn, RC; Rolland, JM	1
Bater, AJ; Deeley, TJ; Kerby, IJ; Pritchard, JA; Siddall, JE; Sutherland, WH	1
Boutorine, AS; Pyshnyï, DV; Repkova, MN; Sergueyeva, ZA; Venyaminova, AG	1
Gruber, M; Kranz, DM; Schodin, BA; Wilson, ER	1
Low, PS; Lu, Y	1
Cozzolino, JP; Dickinson, K; Rotman, B; Teplitz, C	1
Dzbanovskiĭ, NN; Polsachev, VI; Rakhimov, AT; Rubin, LB	1

Reviews

1 review(s) available for fluorescein and Neoplasms

Article	Year
Targeting cancer cells with dendrimers. Chemistry & biology, 2005, Volume: 12, Issue:1 Topics: Carrier Proteins; DNA; Drug Carriers; Fluorescein; Folate Receptors, GPI-Anchored; Humans; Neoplasms; Polyamines; Receptors, Cell Surface	2005

Other Studies

66 other study(ies) available for fluorescein and Neoplasms

Article	Year
Design, Synthesis, and Targeted Delivery of an Immune Stimulant that Selectively Reactivates Exhausted CAR T Cells. Angewandte Chemie (International ed. in English), 2022, 04-04, Volume: 61, Issue:15 Topics: Antigens, Neoplasm; Fluorescein; Humans; Immunotherapy, Adoptive; Neoplasms; Receptors, Chimeric Antigen; T-Lymphocytes; Toll-Like Receptor 7	2022
Specular Reflection Suppression through the Adjustment of Linear Polarization for Tumor Diagnosis Using Fluorescein Sodium. Sensors (Basel, Switzerland), 2022, Sep-02, Volume: 22, Issue:17 Topics: Animals; Contrast Media; Fluorescein; Neoplasms; Reproducibility of Results; Swine	2022
Activity-based ratiometric FRET probe reveals oncogene-driven changes in labile copper pools induced by altered glutathione metabolism. Proceedings of the National Academy of Sciences of the United States of America, 2019, 09-10, Volume: 116, Issue:37 Topics: Copper; Copper Transporter 1; Fluorescein; Fluorescence Resonance Energy Transfer; Glutathione; HEK293 Cells; HeLa Cells; Humans; Image Processing, Computer-Assisted; Molecular Probe Techniques; Neoplasms; Oncogenes; Oxidation-Reduction; Oxidative Stress; Rhodamines; Signal Transduction	2019
Improving selective targeting to cancer-associated fibroblasts by modifying liposomes with arginine based materials. Journal of drug targeting, 2022, Volume: 30, Issue:1 Topics: Arginine; Cancer-Associated Fibroblasts; Cell Line, Tumor; Doxorubicin; Drug Delivery Systems; Fluorescein; Liposomes; Neoplasms	2022
Exchangeability of FITC-SiO₂ Nanoparticles Between Cancer Cells Increases the Range of Drug Delivery. Journal of biomedical nanotechnology, 2018, Jan-01, Volume: 14, Issue:1 Topics: Drug Delivery Systems; Fluorescein; Fluorescein-5-isothiocyanate; Nanoparticles; Neoplasms; Silicon Dioxide	2018
Nitroreductase-Activatable Theranostic Molecules with High PDT Efficiency under Mild Hypoxia Based on a TADF Fluorescein Derivative. ACS applied materials & interfaces, 2019, May-01, Volume: 11, Issue:17 Topics: Animals; Binding Sites; Cell Survival; Fluorescein; HeLa Cells; Humans; Hypoxia; Light; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Docking Simulation; Neoplasms; Nitroreductases; Photochemotherapy; Photosensitizing Agents; Singlet Oxygen; Temperature; Theranostic Nanomedicine; Transplantation, Heterologous	2019
Regulation of CAR T cell-mediated cytokine release syndrome-like toxicity using low molecular weight adapters. Nature communications, 2019, 06-18, Volume: 10, Issue:1 Topics: Animals; Cell Engineering; Cell Line, Tumor; Cytokines; Fluorescein; Folate Receptors, GPI-Anchored; Folic Acid; Humans; Immune System Diseases; Immunotherapy, Adoptive; Lymphocyte Activation; Mice; Neoplasms; Receptors, Chimeric Antigen; Single-Chain Antibodies; Syndrome; T-Lymphocytes; Xenograft Model Antitumor Assays	2019
Synthesis and characterization of Pt(IV) fluorescein conjugates to investigate Pt(IV) intracellular transformations. Bioconjugate chemistry, 2013, Oct-16, Volume: 24, Issue:10 Topics: Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Cisplatin; Fluorescein; Humans; Neoplasms; Optical Imaging; Oxidation-Reduction; Prodrugs	2013
Effect of folate-targeted nanoparticle size on their rates of penetration into solid tumors. ACS nano, 2013, Oct-22, Volume: 7, Issue:10 Topics: Cell Line, Tumor; Fluorescein; Folic Acid; Humans; Molecular Weight; Nanoparticles; Neoplasms; Particle Size; Polyethylene Glycols	2013
Qualitative and quantitative detection of methylation at CpG sites using the fluorescein-dGTP incorporated asymmetric PCR assay strategy. Chemical communications (Cambridge, England), 2014, Jun-25, Volume: 50, Issue:50 Topics: Biological Assay; Cadherins; CpG Islands; Deoxyguanine Nucleotides; DNA Methylation; DNA Primers; Fluorescein; Fluorescence; Humans; Neoplasms; Polymerase Chain Reaction; Promoter Regions, Genetic; Tumor Cells, Cultured	2014
Intracellular delivery of recombinant arginine deiminase (rADI) by heparin-binding hemagglutinin adhesion peptide restores sensitivity in rADI-resistant cancer cells. Molecular pharmaceutics, 2014, Aug-04, Volume: 11, Issue:8 Topics: Amino Acids; Argininosuccinate Synthase; Cell Line, Tumor; Cell Survival; Citrulline; Cytoplasm; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug Resistance, Neoplasm; Endocytosis; Fluorescein; Humans; Hydrolases; Lectins; MCF-7 Cells; Mycobacterium tuberculosis; Neoplasms; Peptides; Recombinant Fusion Proteins	2014
The garlic compound ajoene targets protein folding in the endoplasmic reticulum of cancer cells. Molecular carcinogenesis, 2016, Volume: 55, Issue:8 Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disulfides; Endoplasmic Reticulum; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum-Associated Degradation; Fluorescein; Heat-Shock Proteins; Humans; Microscopy, Electron, Transmission; Neoplasms; Phosphatidylcholines; Plant Extracts; Protein Folding; Sulfoxides; Ubiquitination; Unfolded Protein Response	2016
Fiber-optic triggered release of liposome in vivo: implication of personalized chemotherapy. International journal of nanomedicine, 2015, Volume: 10 Topics: Animals; Antineoplastic Agents; Drug Delivery Systems; Fiber Optic Technology; Fluorescein; Fluorescent Dyes; Gold; Hot Temperature; Humans; Lasers; Light; Liposomes; Male; Metal Nanoparticles; Mice; Mice, Nude; Neoplasms; Optical Fibers; Solvents; Xenograft Model Antitumor Assays	2015
Evaluation of cell viability and T2 relaxivity of fluorescein conjugated SPION-PAMAM third generation nanodendrimers for bioimaging. Materials science & engineering. C, Materials for biological applications, 2016, Volume: 62 Topics: Biocompatible Materials; Cell Line, Tumor; Cell Survival; Contrast Media; Dendrimers; Dextrans; Fluorescein; Humans; Magnetic Resonance Imaging; Magnetite Nanoparticles; MCF-7 Cells; Microscopy, Fluorescence; Neoplasms; Particle Size; Spectroscopy, Fourier Transform Infrared	2016
A smart multifunctional drug delivery nanoplatform for targeting cancer cells. Nanoscale, 2016, Jul-07, Volume: 8, Issue:25 Topics: Antineoplastic Agents; Cell Line, Tumor; Chitosan; Drug Delivery Systems; Drug Liberation; Fluorescein; Gold; Humans; Hydrogels; Hydrogen-Ion Concentration; Isothiocyanates; Metal Nanoparticles; Neoplasms; Nickel	2016
The clinical use of sodium fluorescein and radioactive diiodofluorescein in the localization of tumors of the central nervous system. Minnesota medicine, 1948, Volume: 31, Issue:10 Topics: Brain; Brain Neoplasms; Fluorescein; Minnesota; Neoplasms	1948
Microsystem for field-amplified electrokinetic trapping preconcentration of DNA at poly(ethylene terephthalate) membranes. Analytical chemistry, 2009, Apr-15, Volume: 81, Issue:8 Topics: Analytic Sample Preparation Methods; Cell-Free System; DNA; Electric Conductivity; Electrophoresis; Fluorescein; Membranes, Artificial; Microfluidic Analytical Techniques; Models, Chemical; Neoplasms; Polyethylene Terephthalates; Porosity; Temperature	2009
Synthesis and characterization of circular structures of i-motif tagged with fluoresceins. Bioconjugate chemistry, 2009, Volume: 20, Issue:4 Topics: Base Pairing; Base Sequence; Electrophoretic Mobility Shift Assay; Fluorescein; Hydrogen-Ion Concentration; Hydrolysis; Microinjections; Molecular Probes; Neoplasms; Oligonucleotides; Proteins; Spectrometry, Fluorescence	2009
The combretastatin derivative (Cderiv), a vascular disrupting agent, enables polymeric nanomicelles to accumulate in microtumors. Journal of pharmaceutical sciences, 2010, Volume: 99, Issue:6 Topics: Animals; Antineoplastic Agents; Bibenzyls; Blood Vessels; Fluorescein; Fluorescein-5-isothiocyanate; Hemodynamics; Male; Neoplasms; Oxides; Polymers; Rats; Serum Albumin	2010
Characterization of formulation parameters affecting low molecular weight drug release from in situ forming drug delivery systems. Journal of biomedical materials research. Part A, 2010, Volume: 94, Issue:2 Topics: Antineoplastic Agents; Biocompatible Materials; Drug Carriers; Drug Compounding; Drug Delivery Systems; Excipients; Fluorescein; Fluorescent Dyes; Humans; Lactic Acid; Materials Testing; Microscopy, Electron, Scanning; Molecular Weight; Neoplasms; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Prostheses and Implants; Water	2010
Tuning payload delivery in tumour cylindroids using gold nanoparticles. Nature nanotechnology, 2010, Volume: 5, Issue:6 Topics: Anions; Cations; Cell Line, Tumor; Doxorubicin; Drug Delivery Systems; Fluorescein; Gold; Humans; Least-Squares Analysis; Metal Nanoparticles; Microscopy, Fluorescence; Models, Biological; Neoplasms; Phantoms, Imaging	2010
Treatment of ocular graft-versus-host disease with topical cyclosporine 0.05%. Cornea, 2010, Volume: 29, Issue:12 Topics: Administration, Topical; Adolescent; Adult; Aged; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Dry Eye Syndromes; Female; Fluorescein; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lissamine Green Dyes; Male; Middle Aged; Neoplasms; Retrospective Studies; Surveys and Questionnaires; Tears; Treatment Outcome	2010
Photoresponsive DNA-cross-linked hydrogels for controllable release and cancer therapy. Langmuir : the ACS journal of surfaces and colloids, 2011, Jan-04, Volume: 27, Issue:1 Topics: Azo Compounds; Cell Line, Tumor; Cross-Linking Reagents; Delayed-Action Preparations; DNA; DNA, Complementary; Doxorubicin; Drug Carriers; Fluorescein; Gold; Horseradish Peroxidase; Humans; Hydrogels; Light; Materials Testing; Metal Nanoparticles; Models, Molecular; Neoplasms; Nucleic Acid Hybridization; Phase Transition; Protein Conformation; Stereoisomerism; Thermodynamics	2011
An improved chamber for direct visualisation of chemotaxis. PloS one, 2010, Dec-14, Volume: 5, Issue:12 Topics: Cell Adhesion; Cell Line, Tumor; Chemotaxis; Equipment Design; Fibronectins; Fluorescein; Green Fluorescent Proteins; Humans; Melanoma; Microscopy; Microscopy, Phase-Contrast; Neoplasm Metastasis; Neoplasms; Time Factors	2010
Cancer therapy improvement with mesoporous silica nanoparticles combining targeting, drug delivery and PDT. International journal of pharmaceutics, 2012, Feb-28, Volume: 423, Issue:2 Topics: Cell Death; Chemistry, Pharmaceutical; Drug Carriers; Drug Compounding; Endosomes; Fluorescein; Galactose; HCT116 Cells; Humans; Lysosomes; Microscopy, Confocal; Nanoparticles; Nanotechnology; Neoplasms; Photochemotherapy; Photosensitizing Agents; Porosity; Receptors, Cell Surface; Silicon Dioxide; Technology, Pharmaceutical; Time Factors	2012
Integrin-targeted trifunctional probe for cancer cells: a "seeing and counting" approach. Analytical chemistry, 2012, Nov-06, Volume: 84, Issue:21 Topics: Amides; Cell Count; Cell Line, Tumor; Drug Design; Europium; Fluorescein; Fluorescent Dyes; Heterocyclic Compounds, 1-Ring; Humans; Integrin alphaVbeta3; Molecular Probes; Neoplasms; Oligopeptides	2012
Nitric oxide mediated photo-induced cell death in human malignant cells. International journal of oncology, 2003, Volume: 22, Issue:4 Topics: Apoptosis; Blotting, Western; Cell Death; Cell Line, Tumor; Electrophoresis, Polyacrylamide Gel; Fluorescein; Free Radicals; Humans; Immunohistochemistry; Indicators and Reagents; Light; Microscopy, Electron; NADP; Neoplasms; Nitric Oxide; Photochemotherapy; Time Factors	2003
[Fluorescein sodium and cancer diagnosis]. Strahlentherapie, 1952, Volume: 88, Issue:3-4 Topics: Fluorescein; Humans; Neoplasms	1952
Depression of the fluorescence of fluorescein solutions by plasma in cancer. Public health monograph, 1953, Volume: 12 Topics: Blood; Depression; Depressive Disorder; Fluorescein; Fluorescence; Humans; Neoplasms; Solutions	1953
[Experimental production of sarcoma in rat by injections of fluorescein sodium; preliminary report]. Gan, 1953, Volume: 44, Issue:2-3 Topics: Animals; Fluorescein; Injections; Neoplasms; Rats; Sarcoma; Sarcoma, Experimental	1953
[Fluorescein in diagnosis of cancer of the eye and its appendages]. Klinische Monatsblatter fur Augenheilkunde und fur augenarztliche Fortbildung, 1953, Volume: 123, Issue:3 Topics: Eye Neoplasms; Fluorescein; Humans; Neoplasms	1953
[Experimental production of sarcoma in rat by injections of fluorescein sodium]. Gan, 1954, Volume: 45, Issue:2-3 Topics: Animals; Fluorescein; Neoplasms; Neoplasms, Experimental; Rats; Sarcoma; Sarcoma, Experimental	1954
Comparative fluorescein labeling and cytotoxicity studies with human cell strains HeLa, Raos, and 407-liver and with fresh surgical specimens of cervical carcinoma, osteogenic sarcoma, and normal adult liver. Journal of the National Cancer Institute, 1959, Volume: 22, Issue:4 Topics: Adult; Bone Neoplasms; Fluorescein; Humans; Liver; Neoplasms; Osteosarcoma; Research; Tissue Culture Techniques	1959
Fluorescein-protein (globulin) affinities of tumors of the thyroid gland. Annals of surgery, 1960, Volume: 152 Topics: Fluorescein; Fluorescent Dyes; Globulins; Humans; Neoplasms; Thyroid Gland; Thyroid Neoplasms	1960
IMMUNOCHEMICAL STAINING WITH FLUORESCEIN-LABELED ANTIBODIES AS AN AID IN THE STUDY OF SKIN CANCER FORMATION. Journal of the National Cancer Institute, 1965, Volume: 34 Topics: Animals; Antigens; Carcinoma, Squamous Cell; Fluorescein; Fluorescent Antibody Technique; Mice; Neoplasms; Neoplasms, Experimental; Research; Skin Neoplasms; Staining and Labeling	1965
Differential staining of normal and neoplastic tissue with fluorescein-egg albumen. Archives of pathology, 1959, Volume: 68 Topics: Albumins; Coloring Agents; Fluorescein; Humans; Neoplasms; Staining and Labeling	1959
Demonstration of the intracellular location of Rous sarcoma virus antigen by fluorescein-labeled antiserums. Journal of the National Cancer Institute, 1960, Volume: 24 Topics: Fluorescein; Neoplasms; Rous sarcoma virus; Sarcoma	1960
Fluorescein-globulin staining of tumor transplants. Archives of pathology, 1961, Volume: 72 Topics: Animals; Coloring Agents; Fluorescein; Globulins; Neoplasms; Neoplasms, Experimental; Staining and Labeling	1961
Biophysical studies of methods utilizing fluorescein and its derivatives to diagnose brain tumors. Radiology, 1950, Volume: 55, Issue:3 Topics: Brain Neoplasms; Fluorescein; Humans; Neoplasms	1950
Clinical use of radioactive diiodofluorescein in diagnosis and localization of tumors of the central nervous system in 105 consecutive patients. A.M.A. archives of neurology and psychiatry, 1951, Volume: 65, Issue:1 Topics: Brain Neoplasms; Central Nervous System; Fluorescein; Neoplasms; Nervous System; Radioactive Tracers; Radioactivity	1951
The clinical use of radioactive di-iodo-fluorescein in the diagnosis and localization of tumors of the central nervous system. Transactions of the American Neurological Association, 1950, Volume: 51 Topics: Central Nervous System; Fluorescein; Neoplasms; Nervous System; Radioactive Tracers; Radioactivity	1950
The localization of intracranial neoplasms with radioactive diiodofluorescein. The Journal of laboratory and clinical medicine, 1950, Volume: 36, Issue:6 Topics: Brain Neoplasms; Fluorescein; Neoplasms; Radioactive Tracers; Radioactivity	1950
Localization of intracranial neoplasms with radioactive diiodofluorescein. Missouri medicine, 1950, Volume: 47, Issue:12 Topics: Brain Neoplasms; Fluorescein; Neoplasms; Radioactive Tracers; Skull; Skull Neoplasms	1950
Fluorescein in the localization of brain tumors. Proceedings of the staff meetings. Mayo Clinic, 1951, Apr-11, Volume: 26, Issue:8 Topics: Biological Phenomena; Brain Neoplasms; Fluorescein; Neoplasms; Physiological Phenomena	1951
The localization of cerebral tumours with radioactive derivatives of fluorescein; physical limitations. The British journal of radiology, 1951, Volume: 24, Issue:281 Topics: Brain Neoplasms; Fluorescein; Neoplasms; Physical Examination; Radioactive Tracers; Radioactivity	1951
Clinical and experimental studies of intracranial tumors with fluorescein dyes with an additional note concerning the possible use of K42 and iodine 131 tagged human albumin. The American journal of roentgenology and radium therapy, 1951, Volume: 66, Issue:1 Topics: Albumins; Brain Neoplasms; Coloring Agents; Fluorescein; Humans; Iodine; Neoplasms; Radioisotopes	1951
Studies on the blood supply of tumors in man. I. Fluorescence of cutaneous lesions. Journal of the National Cancer Institute, 1951, Volume: 11, Issue:5 Topics: Blood Vessels; Cardiovascular System; Fluorescein; Fluorescence; Humans; Male; Neoplasms; Skin	1951
[Tumor diagnosis with fluorescein sodium]. Medizinische Klinik, 1951, Jul-27, Volume: 46, Issue:30 Topics: Brain Neoplasms; Fluorescein; Humans; Ions; Neoplasms; Sodium; Sodium, Dietary	1951
[Fluorescein test in the diagnosis of cancer]. Acta chirurgica Patavina, 1951, Volume: 7, Issue:2-3 Topics: Fluorescein; Humans; Neoplasms	1951
[Utilization of fluorescein sodium and atebrin in tumor diagnosis]. Munchener medizinische Wochenschrift (1950), 1951, Nov-09, Volume: 93, Issue:45 Topics: Fluorescein; Humans; Neoplasms; Quinacrine	1951
[Addenda on tumor diagnosis with sodium fluorescein]. Medizinische Klinik, 1952, Feb-08, Volume: 47, Issue:6 Topics: Brain; Brain Neoplasms; Fluorescein; Humans; Neoplasms	1952
TNP-470 promotes initial vascular sprouting in xenograft tumors. Molecular cancer therapeutics, 2004, Volume: 3, Issue:3 Topics: Angiogenesis Inhibitors; Angiography; Animals; Antibiotics, Antineoplastic; Apoptosis; Capillaries; Cell Line, Tumor; Cyclohexanes; Fluorescein; Humans; Hypoxia; Immunohistochemistry; In Situ Hybridization; In Situ Nick-End Labeling; Lectins; Mice; Mice, Nude; Microcirculation; Neoplasm Transplantation; Neoplasms; Neovascularization, Pathologic; Nitroimidazoles; O-(Chloroacetylcarbamoyl)fumagillol; Radiation-Sensitizing Agents; Sesquiterpenes; Vascular Endothelial Growth Factor A; Wilms Tumor	2004
A high-throughput fluorescence polarization assay for signal transducer and activator of transcription 3. Analytical biochemistry, 2004, Jul-01, Volume: 330, Issue:1 Topics: Antigens, CD; Cytokine Receptor gp130; DNA-Binding Proteins; Fluorescein; Fluorescence Polarization; Humans; Membrane Glycoproteins; Neoplasms; Peptides; Phosphotyrosine; src Homology Domains; STAT3 Transcription Factor; Trans-Activators	2004
The use of fluorescein dyes in the diagnosis of malignancy with special reference to tumors of the central nervous system. Journal of the National Cancer Institute, 1949, Volume: 10, Issue:2 Topics: Central Nervous System; Coloring Agents; Fluorescein; Humans; Neoplasms; Nervous System	1949
Transfected cell microarrays for the expression of membrane-displayed single-chain antibodies. Analytical chemistry, 2004, Dec-15, Volume: 76, Issue:24 Topics: Antibodies; Antineoplastic Agents; Binding Sites; Cell Line; Cell Membrane; Fluorescein; Gene Expression Regulation; Immunoglobulin Fragments; Immunoglobulin Variable Region; Membrane Proteins; Mutation; Neoplasms; Oligonucleotide Array Sequence Analysis; Transfection	2004
Inhibition of the hyaluronan-CD44 interaction by merlin contributes to the tumor-suppressor activity of merlin. Oncogene, 2007, Feb-08, Volume: 26, Issue:6 Topics: Actins; Amino Acids; Animals; Base Sequence; Cell Line; Cell Proliferation; Cytoskeletal Proteins; Cytoskeleton; Fluorescein; Gene Deletion; Hyaluronan Receptors; Hyaluronic Acid; Mice; Molecular Sequence Data; Mutation; Neoplasms; Neurofibromin 2; Promoter Regions, Genetic; Protein Binding; RNA Interference; Tumor Suppressor Proteins	2007
Breeding and building molecules to spy on cells and tumors. The Keio journal of medicine, 2006, Volume: 55, Issue:4 Topics: Animals; Arsenicals; Bacterial Proteins; Fluorescein; Fluorescence Resonance Energy Transfer; Green Fluorescent Proteins; Humans; Luminescent Proteins; Neoplasms; Receptors, AMPA; Red Fluorescent Protein; Somatic Hypermutation, Immunoglobulin	2006
Significance of Distribution of Fluorescein in Sarcoma 180. Science (New York, N.Y.), 1948, Sep-17, Volume: 108, Issue:2803 Topics: Animals; Fluorescein; Humans; Neoplasms; Sarcoma; Sarcoma 180	1948
Significance of lymphocyte fluorescence polarization changes after phytohemagglutinin stimulation in cancer and noncancer conditions. Journal of the National Cancer Institute, 1984, Volume: 72, Issue:2 Topics: Cyclic AMP; Cyclic GMP; Female; Fluorescein; Fluoresceins; Fluorescence Polarization; Humans; In Vitro Techniques; Lymphocytes; Male; Neoplasms; Phytohemagglutinins; Pregnancy	1984
Fluorescent lymphocyte probes for cancer detection. Annals of the New York Academy of Sciences, 1983, Volume: 420 Topics: 1-Naphthylamine; Acridine Orange; Fluorescein; Fluoresceins; Fluorescence Polarization; Humans; Lymphocyte Activation; Lymphocytes; Neoplasms	1983
Fluorescent probes for the detection of malignant disease. Annals of the New York Academy of Sciences, 1983, Volume: 420 Topics: 1-Naphthylamine; Carcinoma; Cell Separation; Female; Flow Cytometry; Fluorescein; Fluoresceins; Humans; Lymphocyte Activation; Lymphocytes; Neoplasms; Ovarian Neoplasms; Uterine Cervical Neoplasms	1983
Effect of derivatization of ribophosphate backbone and terminal ribophosphate groups in oligoribonucleotides on their stability and interaction with eukaryotic cells. Biochimie, 1994, Volume: 76, Issue:1 Topics: Animals; Base Sequence; Cholesterol; Chromatography, High Pressure Liquid; Elapid Venoms; Electrophoresis, Polyacrylamide Gel; Fluorescein; Fluoresceins; Humans; Molecular Sequence Data; Neoplasms; Oligodeoxyribonucleotides; Oligoribonucleotides; Phosphoric Diester Hydrolases; Structure-Activity Relationship; Tumor Cells, Cultured	1994
Efficient tumor cell lysis mediated by a bispecific single chain antibody expressed in Escherichia coli. Journal of immunology (Baltimore, Md. : 1950), 1994, Jun-01, Volume: 152, Issue:11 Topics: Amino Acid Sequence; Animals; Antibodies, Bispecific; Base Sequence; Cytotoxicity, Immunologic; Escherichia coli; Fluorescein; Fluoresceins; Humans; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Neoplasms; Receptors, Antigen, T-Cell; T-Lymphocytes, Cytotoxic	1994
Folate targeting of haptens to cancer cell surfaces mediates immunotherapy of syngeneic murine tumors. Cancer immunology, immunotherapy : CII, 2002, Volume: 51, Issue:3 Topics: Animals; Cytokines; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Fluorescein; Folic Acid; Haptens; Immunoglobulin G; Immunotherapy; Interferon-alpha; Interferon-gamma; Interleukin-2; Kinetics; Mice; Mice, Inbred BALB C; Microscopy, Fluorescence; Models, Chemical; Neoplasms; Time Factors; Tumor Cells, Cultured	2002
Individual human tumors in short-term micro-organ cultures: chemosensitivity testing by fluorescent cytoprinting. In vitro cellular & developmental biology : journal of the Tissue Culture Association, 1988, Volume: 24, Issue:11 Topics: Antineoplastic Agents; Cell Survival; Fluorescein; Fluoresceins; Humans; Microscopy, Fluorescence; Necrosis; Neoplasms; Organ Culture Techniques; Time Factors	1988
[Sodium fluorescein-sensitized fluorescent diagnosis of malignant neoplasms]. Doklady Akademii nauk SSSR, 1986, Volume: 287, Issue:6 Topics: Fluorescein; Fluoresceins; Humans; Neoplasms; Spectrometry, Fluorescence; Stomach Neoplasms	1986